Ban‐Feng Ruan

1.6k total citations
79 papers, 1.3k citations indexed

About

Ban‐Feng Ruan is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Ban‐Feng Ruan has authored 79 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Organic Chemistry, 19 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Ban‐Feng Ruan's work include Synthesis and biological activity (20 papers), Metal complexes synthesis and properties (13 papers) and Ferrocene Chemistry and Applications (10 papers). Ban‐Feng Ruan is often cited by papers focused on Synthesis and biological activity (20 papers), Metal complexes synthesis and properties (13 papers) and Ferrocene Chemistry and Applications (10 papers). Ban‐Feng Ruan collaborates with scholars based in China, Australia and Switzerland. Ban‐Feng Ruan's co-authors include Hai‐Liang Zhu, Chenzhong Liao, Xueqin Hu, Yupeng Tian, Jun Xu, Xianfeng Huang, Jieying Wu, Ling‐Yi Kong, Yoshiaki Takaya and Qing‐Shan Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Ban‐Feng Ruan

71 papers receiving 1.3k citations

Peers

Ban‐Feng Ruan
Alberto Massarotti Italy
Bruno Tasso Italy
S. Nanjunda Swamy India
Subhas S. Karki India
Rossella Fioravanti Italy
H. Piotrowska Poland
Alessia Bertamino Italy
Arunasree M. Kalle India
Alberto Massarotti Italy
Ban‐Feng Ruan
Citations per year, relative to Ban‐Feng Ruan Ban‐Feng Ruan (= 1×) peers Alberto Massarotti

Countries citing papers authored by Ban‐Feng Ruan

Since Specialization
Citations

This map shows the geographic impact of Ban‐Feng Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ban‐Feng Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ban‐Feng Ruan more than expected).

Fields of papers citing papers by Ban‐Feng Ruan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ban‐Feng Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ban‐Feng Ruan. The network helps show where Ban‐Feng Ruan may publish in the future.

Co-authorship network of co-authors of Ban‐Feng Ruan

This figure shows the co-authorship network connecting the top 25 collaborators of Ban‐Feng Ruan. A scholar is included among the top collaborators of Ban‐Feng Ruan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ban‐Feng Ruan. Ban‐Feng Ruan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ruan, Ban‐Feng, et al.. (2025). Iron-Catalyzed Radical Hydrothiolation of gem-Difluoroalkenes. Organic Letters. 27(33). 9293–9298.
3.
Varghese, Swapna, et al.. (2024). Drug discovery and optimization based on the co-crystal structure of natural product with target. European Journal of Medicinal Chemistry. 266. 116126–116126. 11 indexed citations
4.
Ruan, Ban‐Feng, Ke Wang, Xiaohan Liu, et al.. (2023). Discovery of pterostilbene analogs as novel NLRP3 inflammasome inhibitors for potential treatment of DSS-induced colitis in mice. Bioorganic Chemistry. 133. 106429–106429. 12 indexed citations
5.
6.
Luo, Shuying, et al.. (2020). Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds. Current Medicinal Chemistry. 28(5). 940–962. 13 indexed citations
7.
Preston, Sarah, José Garcia-Bustos, Sheree D. Martin, et al.. (2020). 1-Methyl-1H-pyrazole-5-carboxamide Derivatives Exhibit Unexpected Acute Mammalian Toxicity. Journal of Medicinal Chemistry. 64(1). 840–844. 7 indexed citations
8.
Ruan, Ban‐Feng, Yuezhou Zhang, Solomon Tadesse, et al.. (2020). Synthesis and structure-activity relationship study of pyrrolidine-oxadiazoles as anthelmintics against Haemonchus contortus. European Journal of Medicinal Chemistry. 190. 112100–112100. 17 indexed citations
9.
Yang, Yang, Xueqin Hu, Qing‐Shan Li, et al.. (2015). Metalloprotein Inhibitors for the Treatment of Human Diseases. Current Topics in Medicinal Chemistry. 16(4). 384–396. 31 indexed citations
10.
Li, Qing‐Shan, et al.. (2015). Discovery of Novel Dinitrobenzotrifluoride Containing o-Hydroxybenzylamine Derivatives as Potential Antibacterial Agents. Medicinal Chemistry. 11(3). 305–313. 2 indexed citations
11.
Ge, Xiaolin, et al.. (2013). 2,4-Dimethoxy-6-[(E)-2-(4-methoxyphenyl)ethenyl]benzaldehyde. Acta Crystallographica Section E Structure Reports Online. 69(5). o629–o629. 3 indexed citations
12.
Ruan, Ban‐Feng, Xiaoqin Lu, Jie Song, & Hai‐Liang Zhu. (2012). Derivatives of Resveratrol: Potential Agents in Prevention and Treatment of Cardiovascular Disease. Current Medicinal Chemistry. 19(24). 4175–4183. 21 indexed citations
13.
Yao, Risheng, et al.. (2012). Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents. European Journal of Medicinal Chemistry. 62. 222–231. 17 indexed citations
14.
15.
Ruan, Ban‐Feng & Hai‐Liang Zhu. (2012). The Chemistry and Biology of the Bryostatins: Potential PKC Inhibitors in Clinical Development. Current Medicinal Chemistry. 19(16). 2652–2664. 51 indexed citations
16.
Lu, Xiang, Hui Zhang, Guo Chen, et al.. (2011). Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors. Bioorganic & Medicinal Chemistry. 19(22). 6827–6832. 38 indexed citations
17.
Ruan, Ban‐Feng, Xiang Lu, Jianfeng Tang, et al.. (2011). Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents. Bioorganic & Medicinal Chemistry. 19(8). 2688–2695. 62 indexed citations
18.
Ruan, Ban‐Feng, et al.. (2011). Synthesis and Biological Activity of Chiral Dihydropyrazole: Potential Lead for Drug Design. Mini-Reviews in Medicinal Chemistry. 11(9). 771–821. 56 indexed citations
19.
Huang, Xianfeng, Huan‐Qiu Li, Lei Shi, et al.. (2008). Synthesis of Resveratrol Analogues, and Evaluation of Their Cytotoxic and Xanthine Oxidase Inhibitory Activities. Chemistry & Biodiversity. 5(4). 636–642. 21 indexed citations
20.
Huang, Xianfeng, Hui Ding, Hui Ming Ge, et al.. (2007). Synthesis and Cytotoxic Evaluation of Substituted Urea Derivatives as Inhibitors of Human‐Leukemia K562 Cells. Chemistry & Biodiversity. 4(5). 881–886. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Massarotti Breakdown of academic impact, for papers by Bruno Tasso Breakdown of academic impact, for papers by S. Nanjunda Swamy Breakdown of academic impact, for papers by Subhas S. Karki Breakdown of academic impact, for papers by Rossella Fioravanti Breakdown of academic impact, for papers by H. Piotrowska Breakdown of academic impact, for papers by Alessia Bertamino Breakdown of academic impact, for papers by Arunasree M. Kalle
Rankless by CCL
2026